From Tabloids to Reliable Scientific Evidence: The Journey of Information Matters

المقدمة

سجل الان

Over the past couple of months, we have been receiving concerns from customers regarding various safety issues with Incretin based therapy. Some verbatims have been shared with the customer-facing teams, and we believe that our confidence in the reliability of these medications should be clearly communicated through scientific evidence. The primary objective of this meeting is to underscore the significance of validated information over social media posts.

الأهداف

To address concerns regarding the clinical profile of GLP-1 RAs and to assist healthcare professionals in understanding recent scientific evidence about the safety of injectable incretins.

المتحدثين

Dr. Khadija Hafidh, MD, FRCP (Edin)

Consultant Physician and Diabetologist; Dept of Internal Medicine; Diabetes Unit; Rashid Hospital, Dubai Health Authority

Prof. Alex Miras

Professor of Endocrinology at Ulster University. His clinical and research work focus solely on Obesity and type 2 diabetes. He has contributed to the clinical management and research in Obesity over the last 14 years, through his work at a high throughput Obesity Centre. The specialist interests of his research Group are the mechanisms of action of interventions for obesity, focusing on pharmacotherapy, medical devices and obesity surgery.